Cyclometalated and NNN Terpyridine Ruthenium Photocatalysts and Their Cytotoxic Activity

The cyclometalated terpyridine complexes [Ru(η2-OAc)(NC-tpy)(PP)] (PP = dppb 1, (R,R)-Skewphos 4, (S,S)-Skewphos 5) are easily obtained from the acetate derivatives [Ru(η2-OAc)2(PP)] (PP = dppb, (R,R)-Skewphos 2, (S,S)-Skewphos 3) and tpy in methanol by elimination of AcOH. The precursors 2, 3 are prepared from [Ru(η2-OAc)2(PPh3)2] and Skewphos in cyclohexane. Conversely, the NNN complexes [Ru(η1-OAc)(NNN-tpy)(PP)]OAc (PP = (R,R)-Skewphos 6, (S,S)-Skewphos 7) are synthesized in a one pot reaction from [Ru(η2-OAc)2(PPh3)2], PP and tpy in methanol. The neutral NC-tpy 1, 4, 5 and cationic NNN-tpy 6, 7 complexes catalyze the transfer hydrogenation of acetophenone (S/C = 1000) in 2-propanol with NaOiPr under light irradiation at 30 °C. Formation of (S)-1-phenylethanol has been observed with 4, 6 in a MeOH/iPrOH mixture, whereas the R-enantiomer is obtained with 5, 7 (50-52% ee). The tpy complexes show cytotoxic activity against the anaplastic thyroid cancer 8505C and SW1736 cell lines (ED50 = 0.31-8.53 µM), with the cationic 7 displaying an ED50 of 0.31 µM, four times lower compared to the enantiomer 6.

Enantioselective Cytotoxicity of Chiral Diphosphine Ruthenium(II) Complexes Against Cancer Cells

The chiral cationic complex [Ru(η¹‐OAc)(CO)((R,R)‐Skewphos)(phen)]OAc (2^R), isolated from reaction of [Ru(η¹‐OAc)(η²‐OAc)(R,R)‐Skewphos)(CO)] (1^R) with phen, reacts with NaOPiv and KSAc affording [RuX(CO)((R,R)‐Skewphos)(phen)]Y (X=Y=OPiv 3^R; X=SAc, Y=OAc 4^R). The corresponding enantiomers 2^S‐4^S have been obtained from 1^S containing (S,S)‐Skewphos. Reaction of 2^R and 2^S with (S)‐cysteine and NaPF₆ at pH=9 gives the diastereoisomers [Ru((S)‐Cys)(CO)(PP)(phen)]PF₆ (PP=(R,R)‐Skewphos 2^R‐Cys; (S,S)‐Skewphos 2^S‐Cys). The DFT energetic profile for 2^R with (S)‐cysteine in H₂O indicates that aquo and hydroxo species are involved in formation of 2^R‐Cys. The stability of the ruthenium complexes in 0.9 % w/v NaCl solution, PBS and complete DMEM medium, as well as their n‐octanol/water partition coefficient (logP), have been evaluated. The chiral complexes show high cytotoxic activity against SW1736, 8505 C, HCT‐116 and A549 cell lines with EC₅₀ values of 2.8–0.04 μM. The (R,R)‐Skewphos derivatives show higher cytotoxicity compared to their enantiomers, 4^R (EC₅₀=0.04 μM) being 14 times more cytotoxic than 4^S against the anaplastic thyroid cancer 8505 C cell line.

Preparation of Neutral trans - cis [Ru(O2CR)2P2(NN)], Cationic [Ru(O2CR)P2(NN)](O2CR) and Pincer [Ru(O2CR)(CNN)P2] (P = PPh3, P2 = diphosphine) Carboxylate Complexes and their Application in the Catalytic Carbonyl Compounds Reduction

The diacetate complexes trans-[Ru(κ¹-OAc)₂(PPh₃)₂(NN)] (NN = ethylenediamine (en) (1), 2-(aminomethyl)pyridine (ampy) (2), 2-(aminomethyl)pyrimidine (ampyrim) (3)) have been isolated in 76-88% yield by reaction of [Ru(κ²-OAc)₂(PPh₃)₂] with the corresponding nitrogen ligands. The ampy-type derivatives 2 and 3 undergo isomerization to the thermodynamically most stable cationic complexes [Ru(κ¹-OAc)(PPh₃)₂(NN)]OAc (2a and 3a) and cis-[Ru(κ¹-OAc)₂(PPh₃)₂(NN)] (2b and 3b) in methanol at RT. The trans-[Ru(κ¹-OAc)₂(P₂)₂] (P₂ = dppm (4), dppe (5)) compounds have been synthesized from [Ru(κ²-OAc)₂(PPh₃)₂] by reaction with the suitable diphosphine in toluene at 95 °C. The complex cis-[Ru(κ¹-OAc)₂(dppm)(ampy)](6) has been obtained from [Ru(κ²-OAc)₂(PPh₃)₂] and dppm in toluene at reflux and reaction with ampy. The derivatives trans-[Ru(κ¹-OAc)₂P₂(NN)] (7-16; NN = en, ampy, ampyrim, 8-aminoquinoline; P₂ = dppp, dppb, dppf, (R)-BINAP) can be easily synthesized from [Ru(κ²-OAc)₂(PPh₃)₂] with a diphosphine and treatment with the NN ligands at RT. Alternatively these compounds have been prepared from trans-[Ru(OAc)₂(PPh₃)₂(NN)] by reaction with the diphosphine in MEK at 50 °C. The use of (R)-BINAP affords trans-[Ru(κ¹-OAc)₂((R)-BINAP)(NN)] (NN = ampy (11), ampyrim (15)) isolated as single stereoisomers. Treatment of the ampy-type complexes 8-15 with methanol at RT leads to isomerization to the cationic derivatives [Ru(κ²-OAc)P₂(NN)]OAc (8a-15a; NN = ampy, ampyrim; P₂ = dppp, dppb, dppf, (R)-BINAP). Similarly to 2, the dipivalate trans-[Ru(κ¹-OPiv)₂(PPh₃)₂(ampy)] (18) is prepared from [Ru(κ²-OPiv)₂(PPh₃)₂] (17) and ampy in CHCl₃. The pincer acetate [Ru(κ¹-OAc)(CNN^OMe)(PPh₃)₂] (19) has been synthesized from [Ru(κ²-OAc)₂(PPh₃)₂] and HCNN^OMe ligand in 2-propanol with NEt₃ at reflux. In addition, the dppb pincer complexes [Ru(κ¹-OAc)(CNN)(dppb)] (CNN = AMTP (20), AMBQ^Ph (21)) have been obtained from [Ru(κ²-OAc)₂(PPh₃)₂], dppb, and HAMTP or HAMBQ^Ph with NEt₃, respectively. The acetate NN and pincer complexes are active in transfer hydrogenation with 2-propanol and hydrogenation with H₂ of carbonyl compounds at S/C values of up to 10000 and with TOF values of up to 160000 h^-1.

Cationic carboxylate and thioacetate ruthenium(ii) complexes: synthesis and cytotoxic activity against anaplastic thyroid cancer cells

The cationic acetate ruthenium complex [Ru(η1-OAc)(CO)(dppb)(phen)]OAc (1) is easily prepared in 83% yield from [Ru(η1-OAc)(η2-OAc)(CO)(dppb)] (dppb = 1,4-bis(diphenylphosphino)butane) and 1,10-phenanthroline (phen) in MeOH. The derivative 1 undergoes easy substitution of the coordinated acetate by reaction with NaOPiv, KSAc, and KSCN in MeOH, affording the corresponding complexes [RuX(CO)(dppb)(phen)]X (X = OPiv, 2; SAc, 3; and NCS, 4), whereas its reaction with NaCl and NH4PF6 affords [RuCl(CO)(dppb)(phen)]PF6 (5). Carboxylate complexes 1 and 2 show high solubility in water, enabling easy exchange of the coordinated carboxylate by water and other ligands (CH3CN, glutathione). Cationic complexes 1-5, compared to Cisplatin, display a strong cell viability decrease in two human anaplastic thyroid cancer cell lines (SW1736 and 8505C), ranging from 3.10 μM to 0.09 μM EC50 values. The most active compounds 1-3 show a marked increment of apoptosis and decrease of cancer cell aggressiveness, making them promising candidates for further evaluation studies.

Transfer Hydrogenation from 2-propanol to Acetophenone Catalyzed by [RuCl2(η6-arene)P] (P = monophosphine) and [Rh(PP)2]X (PP = diphosphine, X = Cl−, BF4−) Complexes

The reduction of ketones through homogeneous transfer hydrogenation catalyzed by transition metals is one of the most important routes for obtaining alcohols from carbonyl compounds. The interest of this method increases when opportune catalytic precursors are able to perform the transformation in an asymmetric fashion, generating enantiomerically enriched chiral alcohols. This reaction has been extensively studied in terms of catalysts and variety of substrates. A large amount of information about the possible mechanisms is available nowadays, which has been of high importance for the development of systems with excellent outcomes in terms of conversion, enantioselectivity and Turn Over Frequency. On the other side, many mechanistic aspects are still unclear, especially for those catalytic precursors which have shown only moderate performances in transfer hydeogenation. This is the case of neutral [RuCl2(η6-arene)(P)] and cationic [Rh(PP)2]X (X = anion; P and PP = mono- and bidentate phosphine, respectively) complexes. Herein, a summary of the known information about the Transfer Hydrogenation catalyzed by these complexes is provided with a continuous focus on the more relevant mechanistic features.